Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury

被引:45
作者
Fock, J
Galea, MP
Stillman, BC
Rawicki, B
Clark, M
机构
[1] Brighton Rehabil Ctr, Brighton, Vic 3186, Australia
[2] Univ Melbourne, Sch Physiotherapy, Parkville, Vic 3010, Australia
[3] Monash Univ, Dept Math & Stat, Clayton, Vic 3168, Australia
关键词
D O I
10.1080/0269905031000149498
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Primary objective : The aim of this study was to assess the effect of Botulinum toxin A in the management of spastic equinus resulting from traumatic brain injury. Research design : A before-after intervention design was used without controls. Methods and procedures : Subjects were seven patients suffering from traumatic brain injury of average duration 14 (4-38) months as a result of motor vehicle trauma, who had spastic equinus interfering with gait. Experimental intervention : The patients were treated with injections of Botulinum toxin A into the spastic calf muscles: gastrocnemius, soleus and tibialis posterior. Assessments were made pre-injection and at 2 weeks and 3 months post-injection. Main outcome and results : At the end of the 3-month period, all patients showed a significant improvement in gait velocity, cadence and stride length. Conclusions : The findings suggest that Botulinum toxin A may be useful in the management of spastic equinus following traumatic brain injury.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 21 条
[1]  
*AM AC ORTH SURG, 1965, JOINT MOT METH MEAS, P68
[2]   INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY [J].
BOHANNON, RW ;
SMITH, MB .
PHYSICAL THERAPY, 1987, 67 (02) :206-207
[3]   PHENOL NERVE BLOCK IN TREATMENT OF ACQUIRED SPASTIC HEMIPLEGIA IN UPPER LIMB [J].
BRAUN, RM ;
HOFFER, MM ;
MOONEY, V ;
MCKEEVER, J ;
ROPER, B .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1973, A 55 (03) :580-585
[4]   A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients [J].
Burbaud, P ;
Wiart, L ;
Dubos, JL ;
Gaujard, E ;
Debelleix, X ;
Joseph, PA ;
Mazaux, JM ;
Bioulac, B ;
Barat, M ;
Lagueny, A .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) :265-269
[5]   EFFECT OF TREATMENT WITH BOTULINUM TOXIN ON SPASTICITY [J].
DAS, TK ;
PARK, DM .
POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (762) :208-210
[6]   TREATMENT OF CHRONIC LIMB SPASTICITY WITH BOTULINUM TOXIN-A [J].
DUNNE, JW ;
HEYE, N ;
DUNNE, SL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (02) :232-235
[7]  
Glenn M., 1990, PRACTICAL MANAGEMENT, P227
[8]   BOTULINUM TOXIN TREATMENT FOR LOWER-LIMB EXTENSOR SPASTICITY IN CHRONIC HEMIPARETIC PATIENTS [J].
HESSE, S ;
LUCKE, D ;
MALEZIC, M ;
BERTELT, C ;
FRIEDRICH, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (11) :1321-1324
[9]   Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients [J].
Hesse, S ;
Krajnik, J ;
Luecke, D ;
Jahnke, MT ;
Gregoric, M ;
Mauritz, KH .
STROKE, 1996, 27 (03) :455-460
[10]   Botulinum toxin A in the treatment of spasticity: Functional implications and patient selection [J].
Pierson, SH ;
Katz, DI ;
Tarsy, D .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (07) :717-721